Phibro Animal Health (PAHC) Tops Q1 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Qtrex Quantum executives plan to buy up to 2M shares over 12 months
Phibro Animal Health Corporation Declares Quarterly Dividend
November 9, 2015 4:47 PM ESTTEANECK, N.J., Nov. 09, 2015 (GLOBE NEWSWIRE) -- The Board of Directors of Phibro Animal Health Corporation (Nasdaq: PAHC) today declared a quarterly cash dividend of $0.10 per share on its Class A common stock and Class B common stock, payable on December 23, 2015, to... More
Phibro Animal Health Corporation Declares Quarterly Dividend
November 9, 2015 4:47 PM ESTTEANECK, N.J., Nov. 09, 2015 (GLOBE NEWSWIRE) -- The Board of Directors of Phibro Animal Health Corporation (Nasdaq: PAHC) today declared a quarterly cash dividend of $0.10 per share on its Class A common stock and Class B common stock, payable on December 23, 2015, to... More
Phibro Animal Health Corporation Reports First Quarter
November 9, 2015 4:45 PM ESTTEANECK, N.J., Nov. 09, 2015 (GLOBE NEWSWIRE) -- Phibro Animal Health Corporation (NASDAQ: PAHC) today announced its financial results for its first quarter ended September 30, 2015.
Highlights for the September 2015 quarter (compared to the September 2014 quarter, excluding the prior year milestone payments for licensing of vaccine delivery technology)- Net sales of $187 million, an increase of 3%- Adjusted EBITDA of $27.7 million, an increase of 13%- Adjusted diluted EPS of $0.44 Â compared with $0.36
COMMENTARY Â
I am once again proud of the performance of our team. Despite the economic... More
